In this study, we embarked on the pursuit of identifying differentially expressed genes (DEGs) between EGFR–TKI-sensitive and acquired drug-resistant NSCLC xenograft tumor samples. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.